NMT1 and lymphoma: Altogether, our data suggest that in addition to impacting cell signaling at the plasma membrane, as seen in lymphoma cells [22], the major effects of NMT KOs or PCLX-001 treatment are to drastically reduce mitochondrial respiratory complex I proteins.